Article info

Download PDFPDF
A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate

Authors

  1. Correspondence to:
    Dr S B Cohen
    Department of Rheumatology, St Paul Medical Center, 5939 Harry Hines Blvd, Suite 400, Dallas, TX 75235, USA; stanleycohenradiantresearch.net
View Full Text

Citation

Cohen SB, Moreland LW, Cush JJ the 990145 Study Group, et al
A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate

Publication history

  • Accepted February 19, 2004
  • First published April 13, 2004.
Online issue publication 
January 09, 2022

Article Versions